Ketamine is a prescription-only medicine that may be prescribed off-label by our medical team following a comprehensive assessment to assist in the psychotherapy.
ABOUT DR SOTO-ANGONA
Dr Óscar Soto-Angona is a psychiatrist and clinical researcher specialising in treatment-resistant mental health conditions and psychedelic-assisted psychotherapy.
He combines clinical practice with academic research, leading investigations into psychedelic therapies, altered states of consciousness and the psychological mechanisms underlying therapeutic change.
At The Emerge Clinic, Dr Soto-Angona provides specialist psychiatric consultations and assessments, helping determine patients’ suitability for ketamine-assisted psychotherapy.
OUR PSYCHIATRIC CONSULTANT
The Emerge Clinic is delighted to collaborate with Dr Soto-Angona. Drawing on his clinical experience, psychedelic research and involvement in international clinical trials, he assesses patients’ suitability for ketamine-assisted psychotherapy, reviewing complex psychiatric histories and advising on potential risks, contraindications and appropriate precautions.
PROFESSIONAL BACKGROUND
Dr Óscar Soto-Angona graduated in Medicine from the University of Valladolid in 2016, specialising in Psychiatry at Hospital Universitari Vall d’Hebron in 2021 and completing a PhD in Psychiatry at the Universitat Autònoma de Barcelona in 2026.
He currently combines clinical psychiatry at Parc Sanitari Sant Joan de Déu with research as founder and Principal Investigator of ANIMA, a specialist group investigating the therapeutic potential of altered states of consciousness and psychedelic-assisted treatments.
Dr Soto-Angona has participated in international clinical trials involving psilocybin, ayahuasca, 5-MeO-DMT and esketamine, particularly in treatment-resistant conditions. His doctoral research examined meaning-making and psychological flexibility as mechanisms of change in psychedelic-assisted psychotherapy.
He is also co-founder and Vice-President of the Spanish Society of Psychedelic Medicine (SEMPsi), contributing to research, professional education and the responsible development of psychedelic-assisted treatments.
QUALIFICATIONS & PROFESSIONAL TRAINING
ACADEMIC & PROFESSIONAL APPOINTMENTS
WORKING TOGETHER
Dr Soto-Angona provides specialist psychiatric assessments to determine suitability for ketamine-assisted psychotherapy. Paul Gibson leads the psychotherapeutic journey, while Dr Adam Devany provides medical assessment, prescribing and clinical oversight.